No advantage of dexamethasone over predonisolone for the outcome of standard and intermediate risk childhood acute lymphoblastic leukemia in the Tokyo Children's Cancer Study group L95-14 protocol.

Bibliographic Information

Title
No advantage of dexamethasone over predonisolone for the outcome of standard and intermediate risk childhood acute lymphoblastic leukemia in the Tokyo Children's Cancer Study group L95-14 protocol.
Author
Igarashi S, Manabe A, Ohara A, Kumagai M, Saito T, Okimoto Y, Kamijo T, Isoyama K, Kajiwara M, Sotomatsu M, Sugita K, Sugita K, Maeda M, Yabe H, Kinoshita T, Kaneko T, Hayashi Y, Ikuta K, Hanada R, Tsuchiya M.

Journal

Related Projects

See more

Details

  • CRID
    1010282256862100244
  • Article Type
    journal article
  • Data Source
    • KAKEN

Report a problem

Back to top